{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/108401767"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Forward-looking statements are subject to factors that may cause Alexion's results and plans to differ from those expected, including for example, decisions of regulatory authorities regarding marketing approval or material limitations on the marketing of Soliris for its current or potential new indications, and a variety of other risks set forth from time to time in Alexion's filings with the Sec" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "pharmiweb.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/71746055"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/108401767" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/276044294"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/108401767"] } } }
